Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.
- DOI
- 10.1016/j.prdoa.2024.100239
- Published
- 2024-02-10
- Container
- Clin Park Relat Disord
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.prdoa.2024.100239,
title = {Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.},
author = {Fung VSC and Aldred J and Arroyo MP and Bergquist F and Boon AJW and Bouchard M and Bray S and Dhanani S and Facheris MF and Fisseha N and Freire-Alvarez E and Hauser RA and Jeong A and Jia J and Kukreja P and Soileau MJ and Spiegel AM and Talapala S and Tarakad A and Urrea-Mendoza E and Zamudio J and Pahwa R.},
year = {2024},
journal = {Clin Park Relat Disord},
doi = {10.1016/j.prdoa.2024.100239},
url = {https://doi.org/10.1016/j.prdoa.2024.100239}
}RIS
TY - JOUR TI - Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance. AU - Fung VSC AU - Aldred J AU - Arroyo MP AU - Bergquist F AU - Boon AJW AU - Bouchard M AU - Bray S AU - Dhanani S AU - Facheris MF AU - Fisseha N AU - Freire-Alvarez E AU - Hauser RA AU - Jeong A AU - Jia J AU - Kukreja P AU - Soileau MJ AU - Spiegel AM AU - Talapala S AU - Tarakad A AU - Urrea-Mendoza E AU - Zamudio J AU - Pahwa R. PY - 2024 JO - Clin Park Relat Disord DO - 10.1016/j.prdoa.2024.100239 UR - https://doi.org/10.1016/j.prdoa.2024.100239 ER -
APA
VSC, F., J, A., MP, A., F, B., AJW, B., M, B., S, B., S, D., MF, F., N, F., E, F., RA, H., A, J., J, J., P, K., MJ, S., AM, S., S, T., A, T., E, U., J, Z., & R., P. (2024). Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.. Clin Park Relat Disord. https://doi.org/10.1016/j.prdoa.2024.100239
Source records
- europe-pmc · retrieved 2026-09-26T23:30:22.250Z